(Reuters) - Teva Pharmaceutical Industries Ltd named H Lundbeck A/S Chief Executive Kare Schultz as its new CEO and president, the Israel-based drugmaker said on Monday.

Schultz will succeed Yitzhak Peterburg, who will continue as Teva's interim CEO until Schultz takes over.

(Reporting by Abinaya Vijayaraghavan in Bengaluru)